Hear about the most pressing issues, challenges, trends, and opportunities shaping the future of biopharma manufacturing from leading innovators and key CDMOs. Topics include supply chain constraints, tariffs, increasingly complex pipelines, growing peptide demand, major capacity expansions, rising radiotherapeutics, emerging modalities, and more.

Key sessions include a panel on "Top of the Innovator Manufacturing Agenda," a fireside chat with manufacturing leaders from Fujifilm Biotechnologies and Novartis, a panel on "New Capacity Build-Outs: News, Lessons and Industry Impact," and interviews with innovator and CDMO executives on the issues defining the industry's future.